Combinatorial Effects of Chrysin with Doxorubicin, 5-Fluorouracil, and Cyclophosphamide on Triple-Negative Breast Cancer Cell Line

AuthorSedighe Yosefien
AuthorHamid Madanchien
AuthorAbbas Pakdelen
AuthorParviz Kokhaeien
AuthorMaral Hematien
AuthorNegar Sarmadien
AuthorMajid Sirati-Sabeten
OrcidSedighe Yosefi [0000-0001-5895-7946]en
OrcidHamid Madanchi [0000-0002-6527-7321]en
OrcidAbbas Pakdel [0000-0002-7173-367X]en
OrcidParviz Kokhaei [0000-0001-6544-4209]en
OrcidMaral Hemati [0000-0003-3869-598X]en
OrcidNegar Sarmadi [0009-0005-4027-3040]en
OrcidMajid Sirati-Sabet [0000-0002-8163-7075]en
Issued Date2025-12-31en
AbstractBackground: The primary challenges associated with chemotherapy treatment include the development of drug resistance. Chrysin (CH) has the potential to enhance the therapeutic efficacy of conventional chemotherapeutic agents. Additionally, CH, with its antioxidant properties, can reduce the side effects caused by reactive oxygen species (ROS) from chemotherapy. Objectives: This study focused on investigating the combination impact of CH with either 5-fluorouracil (5-FU), doxorubicin (DOX), or cyclophosphamide (CP) on the triple-negative breast cancer (TNBC) MDA-MB-231 cell line. Methods: Cytotoxicity was investigated using the MTT assay. The checkerboard microplate method was utilized to determine the effects of drug interactions. Apoptosis and cell cycle distribution were measured by flow cytometry. The classical scratch assay was used to examine cell migration ability. Results: The combination of 5-FU and DOX showed synergistic effects with CH (FIX < 1). Conversely, the interaction between CH and CP resulted in non-additive effects (FIX > 1). The combination treatment of CH with a chemotherapeutic drug was more effective in inducing early apoptosis than the drug alone and the control (P < 0.05). An increase in the sub-G1 phase was observed upon treatment with the combination of CH and chemotherapeutic drugs compared with the control and drugs alone (P < 0.05). Co-administration of CH with chemotherapeutic drugs induced a significant decrease in cell migration compared with the control and chemotherapeutic drugs alone (P < 0.05). Conclusions: The results revealed that combination therapy involving CH in conjunction with 5-FU and DOX demonstrated a more substantial therapeutic effect on TNBC cells than treatments with 5-FU and DOX individually.en
DOIhttps://doi.org/10.5812/ijpr-157446en
KeywordCombinatorial Therapyen
KeywordChrysin, Cyclophosphamideen
KeywordDoxorubicinen
Keyword5-Fluorouracilen
KeywordTriple-Negative Breast Canceren
PublisherBrieflandsen
TitleCombinatorial Effects of Chrysin with Doxorubicin, 5-Fluorouracil, and Cyclophosphamide on Triple-Negative Breast Cancer Cell Lineen
TypeResearch Articleen

Files